Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) FCF Margin (2016 - 2025)

Wave Life Sciences (WVE) has disclosed FCF Margin for 11 consecutive years, with 532.45% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, FCF Margin fell 39270.0% year-over-year to 532.45%, compared with a TTM value of 1052.99% through Dec 2025, down 58149.0%, and an annual FY2025 reading of 440.5%, down 30018.0% over the prior year.
  • FCF Margin was 532.45% for Q2 2025 at Wave Life Sciences, up from 688.87% in the prior quarter.
  • Across five years, FCF Margin topped out at 657.69% in Q1 2023 and bottomed at 9158.95% in Q3 2022.
  • Average FCF Margin over 5 years is 1609.19%, with a median of 350.86% recorded in 2021.
  • The sharpest move saw FCF Margin plummeted -908130bps in 2022, then soared 908853bps in 2023.
  • Year by year, FCF Margin stood at 399.32% in 2021, then crashed by -580bps to 2715.42% in 2022, then surged by 96bps to 115.62% in 2023, then fell by -21bps to 139.75% in 2024, then plummeted by -281bps to 532.45% in 2025.
  • Business Quant data shows FCF Margin for WVE at 532.45% in Q2 2025, 688.87% in Q1 2025, and 139.75% in Q2 2024.